As part of Tech.eu's Big Deal feature, this week, we're putting “data orchestration and workflow software for life sciences” Seqera Labs under the microscope and aim to dissect just where the company came from, what part it played in the fight against Covid-19, and what an Addition led €22 million investment round means for the company.

Moreover, instead of just the written word, we managed to sit down with Seqera Labs' CEO and co-founder Evan Flowden and hit the record button.

Read the article in-depth over at Tech.eu.